Signs of platelet activation, but not lipid peroxidation, in fetal blood associated with functional and structural umbilicoplacental lesions in pregnancies complicated by impaired glucose metabolism

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 12, Issue 3, 2002, Pages 165-171

  Saldeen, P ^a   Olofsson, P ^a   Laurini, R N ^a  

^a IVF Unit Curakliniken   (Sweden)

Author keywords

Diabetes; Histology; Placenta; Pregnancy; Prostacyclin; Thromboxane

Indexed keywords

CALCIUM IONOPHORE; MALONALDEHYDE; PROSTACYCLIN; THROMBOXANE A2;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS BLOOD; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIPID PEROXIDATION; PLACENTA DISORDER; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; PROSTAGLANDIN SYNTHESIS; STATISTICAL ANALYSIS; THROMBOCYTE ACTIVATION; UMBILICAL CORD BLOOD; UMBILICAL VEIN;

EID: 0036746809     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.1080/jmf.12.3.165.171     Document Type: Article

References (33)

1. 2 and lipid peroxide levels in type 1 diabetic patients. Diabetes Care 1998;21:1511-16
2. Wang Y, Walsh SW, Guo J, et al. Maternal levels of prostacyclin, thromboxane, vitamin E, and lipid peroxides throughout normal pregnancy. Am J Obstet Gynecol 1991;165:1690-4
3. Morris JM, Gopaul NK, Endresen MJR, et al. Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol 1998;105:1195-9
4. Gutteridge J, Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 1990;15:129-35
5. Wang JA, Zhen EZ, Guo ZZ, et al. Effect of hyperlipidemic serum on lipid peroxidation, synthesis of prostacyclin and thromboxane by cultured endothelial cells: protective effect of antioxidants. Free Radical Biol Med 1989;7:243-9
6. Walsh SW, Wang Y, Jesse R. Peroxide induces vaso-constriction in the human placenta by stimulating thromboxane. Am J Obstet Gynecol 1993;169:1007-12
7. Wong SHY, Knight JA, Hopfer SM, et al. Lipidperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 1987;33:214-20
8. Richard MJ, Portal B, Meo J, et al. Malondialdehyde kit evaluated for determining plasma and lipoprotein fractions that reacts with thiobarbituric acid. Clin Chem 1992;38:704-9
9. Wasowicz W, Neve J, Peretz A. Optimized steps in fluoro-metric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 1993;39:2522-6
10. Lunec J. Oxygen radicals: their measurement and role in major disease. J Int Fed Clin Chem 1992;4:58-63
11. Saldeen P, Olofsson P, Laurini RN. Structural, functional and circulatory placental changes associated with impaired glucose metabolism. Eur J Obstet Gynecol Reprod Biol 2002;in press
12. World Health Organization Expert Committee on Diabetes Mellitus. Technical Report Series No. 727. Geneva: WHO, 1985:9-17
13. Al Frayh AS, Haque KN. Intrauterine and fetal growth standards for Saudi Arabia and the Gulf region. Saudi Med J 1993;14:133-7
14. Saldeen P, Esquivel CO, Björck C-G, et al. Thromboxane production in umbilical vein grafts. Thromb Res 1984;33:259-67
15. Saldeen P, Olofsson P, Parhar RS, et al. Prostanoid production in the umbilicoplacental arterial tree relative to impaired glucose tolerance. Early Hum Dev 1998;50:175-83
16. Laurini RN, Visser GHA, van Ballegooie E, et al. Morphological findings in placentae of insulin-dependent diabetic patients treated with continuous subcutaneous insulin infusion (CSII). Placenta 1987;8:153-65
17. Saldeen P, Olofsson P, Parhar RS, et al. Prostanoid production in umbilical vessels and its relation to glucose tolerance and umbilical artery flow resistance. Eur J Obstet Gynecol Reprod Biol 1996;68:35-41
18. Gisinger C, Schernthaner G. Increased platelet malondialdehyde, but normal platelet sensitivity to adenosine-5-diphosphate and prostacyclin in well-controlled type 1 diabetes without vascular complications. Diabetes Res 1986; 8:401-5
19. Bowen RS, Moodley J, Dutton MF, et al. Oxidative stress in preeclampsia. Acta Obstet Gynecol Scand 2001;80:719-25
20. Walsh SW, Wang Y. Secretion of lipid peroxides by the human placenta. Am J Obstet Gynecol 1993;169:1462-6
21. Rogers MS, Wang W, Mongelli M, et al. Lipid peroxidation in cord blood at birth: a marker of fetal hypoxia during labor. Gynecol Obstet Invest 1997;44:229-33
22. Wang W, Pang CCP, Rogers MS, et al. Lipid peroxidation in cord blood at birth. Am J Obstet Gynecol 1996;174:62-5
23. Yoshioka T, Kawada K, Shimada T, et al. Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Am J Obstet Gynecol 1979;135:372-6
24. 2 in calcium-ionophore-mediated injury to rat gastric mucosal cells. Dig Dis Sci 1999;44:494-502
25. Lagarde M. Cyclic nucleotides and prostaglandins. In Curtis-Prior PB, ed. Prostaglandins: Biology and Chemistry of Prostaglandins and Related Eicosanoids. London: Churchill Livingstone, 1988:147-51
26. Brunkwall JS, Bergqvist D. Prostacyclin release from the human saphenous vein in diabetics is lower than in nondiabetics. World J Surg 1992;16:1141-5
27. 2) in circulation. Acta Biol Med Germ 1978;37:715-23
28. Force T, Milani R, Hibberd P, et al. Aspirin-induced decline in prostacyclin production in patients with coronary artery disease is due to decreased endoperoxide shift. Analysis of the effects of a combination of aspirin and n-3 fatty acids on the eicosanoid profile. Circulation 1991;84:2286-93
29. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001;357:53-6
30. Hunt JV, Wolff SD. Oxidative glycation and free radical production: a causal mechanism of diabetic complications. Free Radical Res Commun 1991;12/13:115-23
31. Laurini R, Laurin J, Marš ál K. Placental histology and fetal blood flow in intrauterine growth retardation. Acta Obstet Gynecol Scand 1994;73:529-34
32. Kristal B, Shurtz-Swirski R, Chezar J, et al. Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patients with essential hypertension. Am J Hypertens 1998;11:921-8
33. Weiss S. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-76